South Korea · Delayed Price · Currency is KRW MEDIPOST Statistics
Total Valuation
MEDIPOST has a market cap or net worth of KRW 349.82 billion. The enterprise value is 317.03 billion.
| Market Cap | 349.82B |
| Enterprise Value | 317.03B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MEDIPOST has 39.09 million shares outstanding. The number of shares has increased by 11.32% in one year.
| Current Share Class | 39.09M |
| Shares Outstanding | 39.09M |
| Shares Change (YoY) | +11.32% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | 1.89% |
| Owned by Institutions (%) | 0.33% |
| Float | 20.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.67 |
| PB Ratio | 1.28 |
| P/TBV Ratio | 1.30 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.24 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.27, with a Debt / Equity ratio of 0.58.
| Current Ratio | 1.27 |
| Quick Ratio | 1.07 |
| Debt / Equity | 0.58 |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.55 |
| Interest Coverage | -6.83 |
Financial Efficiency
Return on equity (ROE) is -8.63% and return on invested capital (ROIC) is -36.54%.
| Return on Equity (ROE) | -8.63% |
| Return on Assets (ROA) | -10.11% |
| Return on Invested Capital (ROIC) | -36.54% |
| Return on Capital Employed (ROCE) | -20.97% |
| Weighted Average Cost of Capital (WACC) | 6.95% |
| Revenue Per Employee | 232.43M |
| Profits Per Employee | -71.66M |
| Employee Count | 322 |
| Asset Turnover | 0.16 |
| Inventory Turnover | 1.43 |
Taxes
| Income Tax | -6.89B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -15.41% in the last 52 weeks. The beta is 0.61, so MEDIPOST's price volatility has been lower than the market average.
| Beta (5Y) | 0.61 |
| 52-Week Price Change | -15.41% |
| 50-Day Moving Average | 8,975.20 |
| 200-Day Moving Average | 16,667.90 |
| Relative Strength Index (RSI) | 46.10 |
| Average Volume (20 Days) | 76,251 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MEDIPOST had revenue of KRW 74.84 billion and -23.08 billion in losses. Loss per share was -608.01.
| Revenue | 74.84B |
| Gross Profit | 47.80B |
| Operating Income | -76.45B |
| Pretax Income | -30.61B |
| Net Income | -23.08B |
| EBITDA | -71.27B |
| EBIT | -76.45B |
| Loss Per Share | -608.01 |
Balance Sheet
The company has 193.47 billion in cash and 160.05 billion in debt, with a net cash position of 33.42 billion or 855.13 per share.
| Cash & Cash Equivalents | 193.47B |
| Total Debt | 160.05B |
| Net Cash | 33.42B |
| Net Cash Per Share | 855.13 |
| Equity (Book Value) | 273.68B |
| Book Value Per Share | 6,986.92 |
| Working Capital | 53.31B |
Cash Flow
In the last 12 months, operating cash flow was -58.05 billion and capital expenditures -4.68 billion, giving a free cash flow of -62.73 billion.
| Operating Cash Flow | -58.05B |
| Capital Expenditures | -4.68B |
| Depreciation & Amortization | 5.18B |
| Net Borrowing | 204.23B |
| Free Cash Flow | -62.73B |
| FCF Per Share | -1,604.91 |
Margins
Gross margin is 63.87%, with operating and profit margins of -102.15% and -30.83%.
| Gross Margin | 63.87% |
| Operating Margin | -102.15% |
| Pretax Margin | -40.89% |
| Profit Margin | -30.83% |
| EBITDA Margin | -95.23% |
| EBIT Margin | -102.15% |
| FCF Margin | n/a |
Dividends & Yields
MEDIPOST does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.32% |
| Shareholder Yield | -11.32% |
| Earnings Yield | -6.60% |
| FCF Yield | -17.93% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 29, 2019. It was a forward split with a ratio of 2.
| Last Split Date | Mar 29, 2019 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
MEDIPOST has an Altman Z-Score of 0.71 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.71 |
| Piotroski F-Score | 1 |